Back to Search
Start Over
Teva presents new Tardive Dyskinesia data at Psych Congress
- Source :
- The Fly. November 1, 2024
- Publication Year :
- 2024
-
Abstract
- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced new patient- and physician-reported interim results from the Phase 4 IMPACT-TD Registry study, revealing differences between TD patients with a [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.814462454